Annual Retained Earnings
-$239.32 M
-$79.70 M-49.93%
March 31, 2024
Summary
- As of February 20, 2025, PRTG annual retained earnings is -$239.32 million, with the most recent change of -$79.70 million (-49.93%) on March 31, 2024.
- During the last 3 years, PRTG annual retained earnings has fallen by -$201.18 million (-527.55%).
- PRTG annual retained earnings is now -1697.48% below its all-time high of $14.98 million, reached on March 31, 2017.
Performance
PRTG Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$242.33 M
-$1.36 M-0.56%
September 30, 2024
Summary
- As of February 20, 2025, PRTG quarterly retained earnings is -$242.33 million, with the most recent change of -$1.36 million (-0.56%) on September 30, 2024.
- Over the past year, PRTG quarterly retained earnings has stayed the same.
- PRTG quarterly retained earnings is now -995.63% below its all-time high of $27.06 million, reached on September 30, 2016.
Performance
PRTG Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PRTG Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -49.9% | 0.0% |
3 y3 years | -527.5% | -340.6% |
5 y5 years | -1310.3% | -1131.1% |
PRTG Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -527.5% | at low | -408.2% | at low |
5 y | 5-year | -1310.3% | at low | -1054.0% | at low |
alltime | all time | -1697.5% | at low | -995.6% | at low |
Portage Biotech Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$242.33 M(+0.6%) |
Jun 2024 | - | -$240.97 M(+0.7%) |
Mar 2024 | -$239.32 M(+49.9%) | -$239.32 M(+13.9%) |
Dec 2023 | - | -$210.07 M(+23.1%) |
Sep 2023 | - | -$170.69 M(+3.1%) |
Jun 2023 | - | -$165.53 M(+3.7%) |
Mar 2023 | -$159.62 M(+190.2%) | -$159.62 M(+144.9%) |
Dec 2022 | - | -$65.17 M(+13.0%) |
Sep 2022 | - | -$57.68 M(+1.7%) |
Jun 2022 | - | -$56.73 M(+3.1%) |
Mar 2022 | -$55.01 M(+44.2%) | -$55.01 M(+15.3%) |
Dec 2021 | - | -$47.69 M(+8.0%) |
Sep 2021 | - | -$44.18 M(+7.2%) |
Jun 2021 | - | -$41.20 M(+8.0%) |
Mar 2021 | -$38.13 M(+71.0%) | -$38.13 M(+43.2%) |
Dec 2020 | - | -$26.64 M(+4.7%) |
Sep 2020 | - | -$25.45 M(+10.7%) |
Jun 2020 | - | -$23.00 M(+3.1%) |
Mar 2020 | -$22.30 M(+31.4%) | -$22.30 M(+6.2%) |
Dec 2019 | - | -$21.00 M(+6.7%) |
Sep 2019 | - | -$19.68 M(+6.9%) |
Jun 2019 | - | -$18.41 M(+8.5%) |
Mar 2019 | -$16.97 M(+18.4%) | -$16.97 M(+12.8%) |
Dec 2018 | - | -$15.04 M(+1.9%) |
Sep 2018 | - | -$14.76 M(+1.4%) |
Jun 2018 | - | -$14.55 M(+1.5%) |
Mar 2018 | -$14.33 M(-195.7%) | -$14.33 M(-202.7%) |
Dec 2017 | - | $13.96 M(-2.5%) |
Sep 2017 | - | $14.31 M(-2.3%) |
Jun 2017 | - | $14.65 M(-2.2%) |
Mar 2017 | $14.98 M(-202.5%) | $14.98 M(-28.6%) |
Dec 2016 | - | $20.98 M(-22.4%) |
Sep 2016 | - | $27.06 M(-291.1%) |
Jun 2016 | - | -$14.16 M(-3.2%) |
Mar 2016 | -$14.62 M(+54.6%) | -$14.62 M(+4.3%) |
Dec 2015 | - | -$14.01 M(+24.5%) |
Sep 2015 | - | -$11.26 M(+9.9%) |
Jun 2015 | - | -$10.24 M(+8.4%) |
Mar 2015 | -$9.45 M(+49.2%) | -$9.45 M(+11.4%) |
Dec 2014 | - | -$8.49 M(+8.1%) |
Sep 2014 | - | -$7.85 M(+10.2%) |
Jun 2014 | - | -$7.12 M(+12.4%) |
Mar 2014 | -$6.33 M(-85.7%) | -$6.33 M(+35.7%) |
Dec 2013 | - | -$4.67 M(+6.7%) |
Sep 2013 | - | -$4.38 M(+8.6%) |
Jun 2013 | - | -$4.03 M(-90.9%) |
Mar 2013 | -$44.16 M | -$44.16 M(-1.1%) |
Dec 2012 | - | -$44.65 M(-1.8%) |
Sep 2012 | - | -$45.45 M(+8.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2012 | - | -$41.85 M(-3.9%) |
Mar 2012 | -$43.56 M(+3.3%) | -$43.56 M(+3.5%) |
Dec 2011 | - | -$42.07 M(+2.6%) |
Sep 2011 | - | -$40.99 M(-5.2%) |
Jun 2011 | - | -$43.23 M(+2.5%) |
Mar 2011 | -$42.18 M(+13.6%) | -$42.18 M(+5.1%) |
Dec 2010 | - | -$40.14 M(+6.0%) |
Sep 2010 | - | -$37.87 M(+5.8%) |
Jun 2010 | - | -$35.81 M(-3.5%) |
Mar 2010 | -$37.11 M(+40.6%) | -$37.11 M(+11.2%) |
Dec 2009 | - | -$33.36 M(+4.0%) |
Sep 2009 | - | -$32.09 M(+11.1%) |
Jun 2009 | - | -$28.89 M(+9.4%) |
Mar 2009 | -$26.40 M(-16.8%) | -$26.40 M(-2.8%) |
Dec 2008 | - | -$27.17 M(-12.3%) |
Sep 2008 | - | -$30.98 M(-3.5%) |
Jun 2008 | - | -$32.09 M(+1.2%) |
Mar 2008 | -$31.72 M(+14.1%) | -$31.72 M(-3.9%) |
Dec 2007 | - | -$32.99 M(+0.8%) |
Sep 2007 | - | -$32.74 M(+8.1%) |
Jun 2007 | - | -$30.29 M(+9.0%) |
Mar 2007 | -$27.80 M(+1.6%) | -$27.80 M(+0.1%) |
Dec 2006 | - | -$27.78 M(-4.2%) |
Sep 2006 | - | -$29.00 M(+0.1%) |
Jun 2006 | - | -$28.98 M(+5.9%) |
Mar 2006 | -$27.37 M(+22.1%) | -$27.37 M(-0.1%) |
Dec 2005 | - | -$27.40 M(+0.6%) |
Sep 2005 | - | -$27.23 M(+17.0%) |
Jun 2005 | - | -$23.28 M(+3.8%) |
Mar 2005 | -$22.42 M(+33.2%) | -$22.42 M(+17.6%) |
Dec 2004 | - | -$19.07 M(+5.8%) |
Sep 2004 | - | -$18.02 M(+7.1%) |
Jun 2004 | - | -$16.82 M(-0.0%) |
Mar 2004 | -$16.83 M(+19.3%) | -$16.83 M(+4.2%) |
Dec 2003 | - | -$16.15 M(+4.6%) |
Sep 2003 | - | -$15.44 M(+0.2%) |
Jun 2003 | - | -$15.40 M(+9.2%) |
Mar 2003 | -$14.11 M(+10.4%) | -$14.11 M(+7.4%) |
Dec 2002 | - | -$13.13 M(+1.5%) |
Sep 2002 | - | -$12.94 M(-4.1%) |
Jun 2002 | - | -$13.49 M(+5.5%) |
Mar 2002 | -$12.78 M(+5.7%) | -$12.78 M(+1.8%) |
Dec 2001 | - | -$12.56 M(+3.1%) |
Sep 2001 | - | -$12.18 M(-3.6%) |
Jun 2001 | - | -$12.64 M(+4.5%) |
Mar 2001 | -$12.09 M(+1.3%) | -$12.09 M(-1.4%) |
Dec 2000 | - | -$12.27 M |
Mar 2000 | -$11.94 M(+12.9%) | - |
Mar 1999 | -$10.57 M(-3.0%) | - |
Mar 1998 | -$10.90 M | - |
FAQ
- What is Portage Biotech annual retained earnings?
- What is the all time high annual retained earnings for Portage Biotech?
- What is Portage Biotech annual retained earnings year-on-year change?
- What is Portage Biotech quarterly retained earnings?
- What is the all time high quarterly retained earnings for Portage Biotech?
- What is Portage Biotech quarterly retained earnings year-on-year change?
What is Portage Biotech annual retained earnings?
The current annual retained earnings of PRTG is -$239.32 M
What is the all time high annual retained earnings for Portage Biotech?
Portage Biotech all-time high annual retained earnings is $14.98 M
What is Portage Biotech annual retained earnings year-on-year change?
Over the past year, PRTG annual retained earnings has changed by -$79.70 M (-49.93%)
What is Portage Biotech quarterly retained earnings?
The current quarterly retained earnings of PRTG is -$242.33 M
What is the all time high quarterly retained earnings for Portage Biotech?
Portage Biotech all-time high quarterly retained earnings is $27.06 M
What is Portage Biotech quarterly retained earnings year-on-year change?
Over the past year, PRTG quarterly retained earnings has changed by $0.00 (0.00%)